
Director · UNITED THERAPEUTICS Corp · UNITED THERAPEUTICS Corp — Restricted Stock Unit
Grant or award — administrative, little informational value
No reported dollar value · new position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $47K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $48K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $186K 320 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 3 | Rothblatt Martine ADirector, Chairperson & CEO | Option exercise · 10b5-1 plan | M | — 9,500 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $127K 221 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $100K 167 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $334K 585 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $46K 80 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $70K 120 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $24K 40 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $321K 562 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $407K 720 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $89K 156 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 10 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $5,998 10 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $293K 520 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 8 | Rothblatt Martine ADirector, Chairperson & CEO | Option exercise · 10b5-1 plan | M | $1.12M 9,500 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $215K 375 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 16 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $337K 560 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $180K 320 sh | Nov 6, 2026 traded Nov 5, 2026 | |
| 13 | Rothblatt Martine ADirector, Chairperson & CEO | Open-market sale · 10b5-1 plan | SELL | $186K 320 sh | Nov 6, 2026 traded Nov 5, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Tracey Kevin filed this Form 4 reporting a grant or award of UTHR on Jan 21, 2026. It became public on Jan 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.